SCPC Expresses Concern Proposed CMS Rule Threatens Seniors’ Access to Essential Medications, Further Undermines LTC Pharmacy Economic Viability
Washington, DC –The Senior Care Pharmacy Coalition (SCPC) today said its initial review of the Centers for Medicare and Medicaid Services (CMS) proposed changes to Medicare Advantage and Part D programs to “lower drug prices and reduce out-of-pocket expenses” would, in actuality, threaten seniors’ access to essential medications, and further undermine the economic viability of long-term care (LTC) pharmacies.
“Our initial analysis of the proposed CMS Rule is that seniors in skilled nursing and assisted living facilities (SNFs/ALFs) will see their access to essential medications curtailed and that LTC pharmacies’ economic viability will be undermined by further empowering prescription drug plans and pharmacy benefit managers (PDPs/PBMs),” warned Alan G. Rosenbloom, President and CEO of SCPC — the only federal advocacy organization devoted exclusively to the interests of the nation’s long-term care (LTC) pharmacies and the patients they serve.
Rosenbloom noted LTC pharmacy economic viability — and ongoing ability to serve the nation’s most frail, vulnerable citizens — has already been placed at substantial risk by the rapid consolidation of PDPs/PBMs, and in related markets like health insurance and retail, specialty, LTC and mail order pharmacies.
“The unchecked and oligopolistic consolidation among gargantuan firms increasingly dominating America’s health care system undercuts the nation’s commitment to free and fair markets. Ultimately, this places unaffiliated pharmacies –- like a majority of the nation’s LTC pharmacies –- at an unfair and exploitative competitive disadvantage, benefitting neither senior consumers nor competition,” the SCPC President and CEO concluded.
LTC pharmacies, a distinct subset within the pharmacy community, serve a specialized population of seniors in SNFs, ALFs and other residential care settings. The typical patient suffers from multiple chronic conditions, significant impairments in daily living activities, mild to moderate dementia, and takes 12-13 prescription medications daily –- making drug prices and access to needed medications an essential variable in maintaining vulnerable seniors’ health and well-being.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 750,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Applauds Bipartisan Group of Lawmakers Calling for Critical Changes to Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement commending Chairman Buddy Carter, Rep. Jake Auchincloss and other Members of Congress for urging HHS and CMS to examine the looming impact of Medicare drug price negotiations on America’s pharmacies.
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.